Aller au contenu principal
Profil bibliographique

Siri Ippagunta

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

56Publications signalées
223Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

CAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesFatty Acid Research and HealthGlioma Diagnosis and Treatment

Les publications récentes

Accès ouvert 2026 article OpenAlex

Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma

Siri Ippagunta, Amir Arabzade, Srinidhi Varadharajan, Erik Emanus et autres

BACKGROUND: Ependymoma (EPN) is the third most common pediatric brain tumor with no targeted therapies available to patients. In supratentorial ependymoma, the most frequent driver alteration is a gene fusion between ZFTA and RELA (denoted ZR), leads to constitutive localization of ZR …

us (code pays fourni par la source)

1 citation Neuro-Oncology
Accès ouvert 2026 article OpenAlex

Dominant clones leverage developmental epigenomic states to drive ependymoma

Alisha Kardian, Hua Sun, Siri Ippagunta, Nicholas Laboe et autres

ZFTA–RELA is the most recurrent genetic alteration seen in paediatric supratentorial ependymoma (EPN) and is sufficient to initiate tumours in mice1. Despite its oncogenic potential, ZFTA–RELA (ZR) is observed nearly exclusively in childhood EPN, with tumours located distinctly in the supratentorial brain …

us, gb (code pays fourni par la source)

0 citations Nature
2026 conference-abstract OpenAlex

Abstract B025: Elucidating the role of ZFTA-RELA in radiation resistance in ependymoma

Blake Holcomb, Ha Won Lee, Pete Hall, Shilpa Narina et autres

Abstract Treatments for childhood brain cancer, the leading cause of disease mortality in children, has not changed in the last three decades and constitutes surgery combined with cytotoxic chemo- and radio- therapy. RT is not always curative, and the mechanisms that promote …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2025 conference-abstract OpenAlex

EXTH-101. CAR T-cells targeted to B7-H3 are effective against ependymomas but show limited response in the immune competent setting

Sanya Mehta, Siri Ippagunta, Alisha Kardian, Srinidhi Varadharajan et autres

Abstract Targeted treatments are desperately needed for ependymomas (EPN). Chimeric antigen receptor (CAR) T-cells have the potential to transform patient outcomes. However, little is known regarding the antitumor efficacy of CAR T-cells against EPNs. We found that B7-H3 is highly and consistently …

us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2025 article OpenAlex

EXTH-74. Nuclear Transport as a Therapeutic Vulnerability in ZFTA-RELA Ependymoma

Siri Ippagunta, Amir Arabzade, Srinidhi Varadharajan, Erik Emanus et autres

Abstract Ependymoma (EPN) is the third most common pediatric brain tumor with no targeted therapies available to patients. The most frequent driver alteration is a gene fusion between ZFTA and RELA (denoted ZR), which leads to constitutive localization of ZR in the …

us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2025 conference-abstract OpenAlex

TMOD-14. Synthetic ZFTA-fusions pinpoint IDR acquisition as a mechanism of brain tumor development

Amir Arabzade, Hazheen K. Shirnekhi, Srinidhi Varadharajan, Siri Ippagunta et autres

Abstract Over 95% of ependymomas (EPN) that arise in the cortex are characterized by gene fusions commonly involving the zinc finger translocation associated (ZFTA) protein. These fusion oncoproteins (FOs) join ZFTA with either a transcription factor or co-activator, leading to a chimeric …

us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2025 article OpenAlex

EPCO-12. DOMINANT MALIGNANT LINEAGE LEVERAGE RESTRICTED EPIGENOMIC PROGRAMS TO DRIVE EPENDYMOMA DEVELOPMENT

Hua Sun, Alisha Kardian, Siri Ippagunta, Nicholas Laboe et autres

Abstract Pediatric cancers are often driven by unique alterations suggesting mechanistic ties to underlying developmental programs. Ependymoma (EPN) is an example of a brain cancer subtype driven by gene fusions involving ZFTA-RELA (ZR) that are exclusive to this disease. This leads to …

us (code pays fourni par la source)

0 citations Neuro-Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.